- Home
- FBIZ vs NVCT Comparison
FBIZ vs NVCT Comparison
Compare FBIZ & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBIZ | NVCT |
|---|---|---|
| Founded | 1909 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 606.1M | 672.1M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FBIZ | NVCT |
|---|---|---|
| Price | $75.50 | $21.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $85.00 | $35.40 |
| AVG Volume (30 Days) | 69.5K | ★ 179.7K |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | ★ 1.79% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 5.24 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.63 | N/A |
| Revenue Next Year | $6.59 | N/A |
| P/E Ratio | $14.37 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $49.36 | $5.77 |
| 52 Week High | $79.53 | $29.28 |
Technical Indicators
Market Signals| Indicator | FBIZ | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 60.08 | 55.75 |
| Support Level | $69.91 | $19.78 |
| Resistance Level | N/A | $22.56 |
| Average True Range (ATR) | 2.10 | 1.53 |
| MACD | 0.15 | 0.31 |
| Stochastic Oscillator | 57.71 | 73.83 |
Price Performance
Historical ComparisonAbout FBIZ First Business Financial Services Inc.
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products, including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically, all the business activity functioned through the region of the United States.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.